{
    "clinical_study": {
        "@rank": "94121", 
        "acronym": "RCSCPSQ", 
        "arm_group": [
            {
                "arm_group_label": "Baclofen", 
                "arm_group_type": "Active Comparator", 
                "description": "The starting dose was 0.75 mg/kg in four divided doses daily and was cautiously increased at three-day intervals until crying subsided or symptoms of over dosage or side effects appeared. The usual maximum dose was two mg/kg in four divided doses daily."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo contained fructose powder in equal quantity in packets mimicking those of Baclofen."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study of recurrent crying spells in Spastic Cerebral Palsy patients and their\n      treatment."
        }, 
        "brief_title": "Recurrent Crying Spells in Cerebral Palsy", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Recurrent Crying Spells", 
        "condition_browse": {
            "mesh_term": "Cerebral Palsy"
        }, 
        "detailed_description": {
            "textblock": "This is the first study of recurrent crying spells in Cerebral Palsy with Spastic\n      quadriparesis depicting the diagnostic criteria and treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Recurrent Crying Spells in Cerebral Palsy with Spastic Quadriparesis.\n\n          -  Age range 0-12 years.\n\n        Exclusion Criteria:\n\n          -  Crying due to known causes (like hunger, sleep, food intolerance etc.),\n\n          -  Crying that responded to routine management (changes in food or feeding techniques,\n             anticolic, analgesics),\n\n          -  Fever of \u2265100.4\u00baF (38\u00baC),\n\n          -  The infant refuses to eat or drink for more than a few hours, vomits excessively, has\n             bloody stools, or has a change in behavior (lethargy or decreased responsiveness).\n\n          -  Colic\n\n          -  Worst ever crying occurring for the first time\n\n          -  Respiratory, renal and hepatic diseases,\n\n          -  Progressive encephalopathies,\n\n          -  Received Baclofen in the previous 30 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955655", 
            "org_study_id": "RCSCPSQ"
        }, 
        "intervention": [
            {
                "arm_group_label": "Baclofen", 
                "description": "Since the therapeutic window of Baclofen is narrow, the lowest dose compatible with an optimal response was used.", 
                "intervention_name": "Baclofen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other", 
                "other_name": "Fructose powder."
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Baclofen"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Baclofen", 
            "cerebral palsy", 
            "colic", 
            "crying infant", 
            "recurrent crying spells", 
            "spasticity", 
            "therapy"
        ], 
        "lastchanged_date": "October 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Secunderabad", 
                    "country": "India", 
                    "state": "Andhra Pradesh", 
                    "zip": "500025"
                }, 
                "name": "Sathbhavana Brain Clinic"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Recurrent Crying Spells in Cerebral Palsy With Spastic Quadriparesis - A Crossover Study", 
        "overall_official": {
            "affiliation": "Sathbhavana Brain Clinic, Secunderabad, India", 
            "last_name": "Nagabhushana Rao Potharaju, BScDCHMDDM", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Cry duration in seconds over a 10-day period while on placebo was compared to that of Baclofen.", 
            "measure": "Change from baseline cry duration in seconds over a 10-day period while on placebo.", 
            "safety_issue": "No", 
            "time_frame": "11th to 20th day and 51st day to 60th day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955655"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sathbhavana Brain Clinic", 
            "investigator_full_name": "Dr.Nagabhushana Rao Potharaju", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Sathbhavana Brain Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sathbhavana Brain Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2005", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}